West-Ward Pharmaceuticals to Pay $10M in Medicaid Fraud Case

Eatonton, N.J.-based West-Ward Pharmaceuticals has agreed to pay $10 million to resolve allegations the pharmaceutical company inflated prescription drug prices to overcharge Texas’ Medicaid program.

Advertisement

The state of Texas alleged West-Ward had been inflating prices for several prescription drugs to the state’s Medicaid program since 1995. The state further alleged as a result of the fraudulent pricing, the Texas Medicaid program reimbursed pharmacies inflated rates for the drugs, according to the settlement agreement.  

Under the agreement, West-Ward will pay $4.5 million to the state of Texas, and because Texas’ Medicaid program is partially funded by U.S. taxpayers, West-Ward will pay $5.5 million to the federal government. 

Although West-Ward has entered into this agreement to settle the Medicaid fraud allegations, it has denied all of the allegations brought against it by the state of Texas, according to the settlement agreement. 

More Articles on Medicaid Fraud:

Michigan Medicaid Fraud Control Unit Case Files Lacked Necessary Documentation, Says OIG 
New Jersey Diagnostic Testing Center Owner Sentenced in Anti-Kickback Case
8 Recent Lawsuits and Settlements Involving Hospitals 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.